Literature DB >> 17270568

Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population.

Bernhard T Baune1, Ina Adrian, Frank Jacobi.   

Abstract

OBJECTIVE: The objective of this study was to compare health-related quality of life (HR-QoL), disability/work productivity, and health care utilization in a variety of medical disorders with and without comorbid major depressive disorder (MDD) in the general population.
METHODS: Twelve-month MDD (Composite International Diagnostic Interview) diagnosis was determined among 4181 participants from a community sample. Medical diagnoses (respiratory, cardiovascular, allergic, endocrine/metabolic, gastrointestinal, and neurological diseases) were made after medical examination. HR-QoL was evaluated with the MOS-SF-36. Outpatient doctor visits and disability/work productivity were assessed by self-report.
RESULTS: Comorbid MDD was associated with a lower SF-36 mental summary score in all medical diagnoses and with a lower physical summary score in comorbid allergic and neurological disorders. The number of coexisting medical disorders was strongly related to lower physical and mental summary scores in cases without comorbid depression. The number of outpatient doctor visits increased by 42% when any of the medical disorders without comorbid MDD was present, and comorbid MDD was associated with a further 24-42% increase, depending on the medical disorder. Comorbid MDD was strongly associated with lower full-time working status (37.1% with MDD vs. 51.0% without MDD) and with a significant increase in disability days (45%) in the presence of any medical disorder.
CONCLUSIONS: Findings have consequences for diagnostic and treatment procedures, as well as in relation to the importance of the number of medical disorders in future studies.

Entities:  

Mesh:

Year:  2007        PMID: 17270568     DOI: 10.1016/j.jpsychores.2006.09.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  22 in total

1.  Psychological and physical functioning difficulties associated with complex activity limitations among U.S. adults.

Authors:  Mitchell Loeb; Bruce S Jonas
Journal:  Disabil Health J       Date:  2014-08-15       Impact factor: 2.554

2.  Gender, depression and physical impairment: an epidemiologic perspective from Aleppo, Syria.

Authors:  Nael Kilzieh; Samer Rastam; Kenneth D Ward; Wasim Maziak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-02       Impact factor: 4.328

Review 3.  Public health significance of neuroticism.

Authors:  Benjamin B Lahey
Journal:  Am Psychol       Date:  2009 May-Jun

4.  Effect of Ketamine, Thiopental and Ketamine-Thiopental Combination during Electroconvulsive Therapy for Depression.

Authors:  Özlem Özkan Kuşçu; Feride Karacaer; Ebru Biricik; Ersel Güleç; Lut Tamam; Yasemin Güneş
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

5.  Rapid antidepressant effects: moving right along.

Authors:  K Martinowich; D V Jimenez; C A Zarate; H K Manji
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

Review 6.  Ketamine and the next generation of antidepressants with a rapid onset of action.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy Diazgranados; Carlos A Zarate
Journal:  Pharmacol Ther       Date:  2009-05-03       Impact factor: 12.310

Review 7.  Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; David A Luckenbaugh; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

Review 8.  The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Neuroscientist       Date:  2009-05-26       Impact factor: 7.519

9.  Association between Cognitive Decline in Older Adults and Use of Primary Care Physician Services in Pennsylvania.

Authors:  Nicole R Fowler; Lisa A Morrow; Li-Chuan Tu; Douglas P Landsittel; Beth E Snitz; Eric G Rodriquez; Judith A Saxton
Journal:  J Prim Care Community Health       Date:  2012-02-11

10.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.